Ascentage Pharma Group In...

NASDAQ: AAPG · Real-Time Price · USD
47.00
0.60 (1.30%)
At close: Aug 20, 2025, 9:40 AM

Ascentage Pharma International Balance Sheet Statement

Financials in CNY. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.24B 1.07B 1.48B 1.71B
Short-Term Investments
47.06M 4.41M 18.7M n/a
Long-Term Investments
33.86M 18.95M 18.53M 4.37M
Other Long-Term Assets
59M 10.05M 361.93M 63.73M
Receivables
99.07M 163.54M 61.49M 54.13M
Inventory
6.6M 16.17M 9.45M 616.63K
Other Current Assets
24.63M 24.54M 16.6M 59.26M
Total Current Assets
1.47B 1.34B 1.64B 295.81M
Property-Plant & Equipment
905.86M 957.23M 650.02M 854.3M
Goodwill & Intangibles
100.69M 110.14M 109M 85.11M
Total Long-Term Assets
1.14B 1.16B 1.19B 1.05B
Total Assets
2.62B 2.5B 2.83B 2.94B
Account Payables
91.97M 72.44M 95.56M 70.86M
Deferred Revenue
54.09M 38.41M 3.5M n/a
Short-Term Debt
769.62M 606.65M 74.57M 39.8M
Other Current Liabilities
22.87M 19.42M 2.82M 58.73M
Total Current Liabilities
1.17B 934.17M 126.75M 361.11M
Long-Term Debt
868.64M 1.17B 1.27B 1.03B
Other Long-Term Liabilities
6.27M 18.3M 35.33M 52.34M
Total Long-Term Liabilities
1.18B 1.5B 1.54B 1.34B
Total Liabilities
2.34B 2.43B 2.42B 1.71B
Total Debt
1.67B 1.8B 1.79B 1.08B
Common Stock
214K 197K 180K 178K
Retained Earnings
-5.77B -5.37B -4.44B -3.56B
Comprehensive Income
-510.59M -504.46M -518.51M n/a
Shareholders Equity
264.19M 60.42M 408.66M 1.23B
Total Investments
33.86M 18.95M 18.53M 27.84M